Arcutis Biotherapeutics GAAP EPS of -$0.13 beats by $0.02, revenue of $81.5M beats by $7.83M

2 hours ago 1

Arcutis Biotherapeutics press release (NASDAQ:ARQT): Q2 GAAP EPS of -$0.13 beats by $0.02.
Revenue of $81.5M (+164.2% Y/Y) beats by $7.83M.
Revenues for the quarter were $27.7 million for ZORYVE cream 0.3%, $14.6 million for ZORYVE cream 0.15%, and $39.2 million for ZORYVE topical

Recommended For You